SG11201806177QA - Transplant material for treatment of heart disease - Google Patents

Transplant material for treatment of heart disease

Info

Publication number
SG11201806177QA
SG11201806177QA SG11201806177QA SG11201806177QA SG11201806177QA SG 11201806177Q A SG11201806177Q A SG 11201806177QA SG 11201806177Q A SG11201806177Q A SG 11201806177QA SG 11201806177Q A SG11201806177Q A SG 11201806177QA SG 11201806177Q A SG11201806177Q A SG 11201806177QA
Authority
SG
Singapore
Prior art keywords
heart disease
treatment
transplant material
heart
transplant
Prior art date
Application number
SG11201806177QA
Inventor
Daisuke Kajita
Satsuki Fukushima
Shigeru Miyagawa
Yoshiki Sawa
Original Assignee
Univ Osaka
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Osaka filed Critical Univ Osaka
Publication of SG11201806177QA publication Critical patent/SG11201806177QA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Abstract

TRANSPLANT MATERIAL FOR TREATMENT OF HEART DISEASE [] It has been found that a cell cluster obtained by causing just isolated cells to adhere to each other 5 secretes adiponectin after transplantation to the heart, and thereby has an excellent therapeutic effect on heart disease. Figures 4A, 4B and 4C 10
SG11201806177QA 2016-01-19 2017-01-18 Transplant material for treatment of heart disease SG11201806177QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016008096 2016-01-19
PCT/JP2017/001538 WO2017126549A1 (en) 2016-01-19 2017-01-18 Transplant material for therapy for heart disease

Publications (1)

Publication Number Publication Date
SG11201806177QA true SG11201806177QA (en) 2018-08-30

Family

ID=59362376

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201806177QA SG11201806177QA (en) 2016-01-19 2017-01-18 Transplant material for treatment of heart disease

Country Status (6)

Country Link
US (1) US20210187031A1 (en)
EP (1) EP3406255B1 (en)
JP (1) JP6854519B2 (en)
CN (1) CN108472319B (en)
SG (1) SG11201806177QA (en)
WO (1) WO2017126549A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3530276A4 (en) * 2016-10-18 2020-05-27 Osaka University Kit for preparing disease-treating agent, disease-treating agent and method for preparing disease-treating agent
EP3733838A4 (en) 2017-12-28 2021-11-03 Kaneka Corporation Cell population including adhesive stem cells, method for producing such cell population, and pharmaceutical composition
US20200368291A1 (en) 2017-12-28 2020-11-26 Kaneka Corporation Cell population including adhesive stem cells, production method therefor and pharmaceutical composition
WO2019187918A1 (en) * 2018-03-29 2019-10-03 国立大学法人 琉球大学 Method for preventing incorporation of undifferentiated ips cells possibly having tumorigenic potential using differentiation-controlling compound
JPWO2020184350A1 (en) 2019-03-08 2020-09-17
WO2021045190A1 (en) * 2019-09-05 2021-03-11 国立大学法人東北大学 Therapeutic agent for myocarditis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005047491A2 (en) * 2003-11-10 2005-05-26 Amgen Inc. Methods of using g-csf mobilized c-kit+cells in the production of embryoid body-like cell clusters for tissue repair and in the treatment of cardiac myopathy
DE602005026724D1 (en) * 2005-05-25 2011-04-14 Cytori Therapeutics Inc METHOD FOR THE USE OF FAT-FROZEN CELLS IN THE TREATMENT OF HEART CIRCUIT SLEEPING
CN101517069A (en) * 2006-07-13 2009-08-26 塞拉帝思股份公司 A novel population of multipotent cardiac precursor cells derived from human blastocysts derived stem cells
EP2044196A2 (en) * 2006-07-13 2009-04-08 Cellartis AB A novel population of multipotent cardiac precursor cells derived from human blastocysts derived stem cells
JPWO2008153179A1 (en) * 2007-06-14 2010-08-26 財団法人先端医療振興財団 Adipose tissue-derived multilineage progenitor cells
SG11201405257WA (en) * 2012-03-12 2014-09-26 Univ Singapore Generation of brown adipose tissue (bat) from mesenchymal cells
CA2875294C (en) * 2012-04-25 2021-06-08 Riken Cell preparation containing myocardium-committed cell

Also Published As

Publication number Publication date
CN108472319B (en) 2021-12-28
JPWO2017126549A1 (en) 2018-11-08
WO2017126549A1 (en) 2017-07-27
EP3406255A4 (en) 2019-08-14
JP6854519B2 (en) 2021-04-07
EP3406255B1 (en) 2023-06-07
US20210187031A1 (en) 2021-06-24
EP3406255A1 (en) 2018-11-28
EP3406255C0 (en) 2023-06-07
CN108472319A (en) 2018-08-31

Similar Documents

Publication Publication Date Title
SG11201806177QA (en) Transplant material for treatment of heart disease
NZ765695A (en) Immune cell organoid co-cultures
MX2019014009A (en) Improved methods for manufacturing adoptive cell therapies.
WO2016012544A3 (en) Enhanced reprogramming to ips cells
WO2016090178A3 (en) Processes for producing exosomes in reduced oxygen culture conditions
NZ731789A (en) Isoindoline derivative, intermediate, preparation method, pharmaceutical composition and use thereof
TW201612312A (en) Meristematic plant cells and method of isolating them
PH12017501218A1 (en) Rpe cell populations and methods of generating same
EP4275746A3 (en) Extracellular vesicles derived from osteoblastic lineage cells for therapeutic and diagnostic use
EP3489351A4 (en) Cell cultivation method, suspended cell elimination method, and method to kill suspended cells
MX2021000459A (en) Method for producing î³î´ t cells.
MX2020005640A (en) Humanized anti-liv1 antibodies for the treatment of breast cancer.
EA201890442A1 (en) OBTAINING PHOTORECEPTORS FOR THE TREATMENT OF RETITAL DISEASES
MX2020011254A (en) Anti-bcma car-t-cells for plasma cell depletion.
WO2018146679A3 (en) Photoreceptor cells for the treatment of retinal diseases
EP3719890A4 (en) Negative electrode active substance and production method therefor
EP3890073A4 (en) Negative electrode material, battery and method for producing battery
EP3641807A4 (en) Adoptive t cell therapy 2
MX2018002816A (en) Methods of treating multiple myeloma and plasma cell leukemia by t cell therapy.
EP4032855A4 (en) Negative electrode active substance, negative electrode, and methods for producing these
EP3608398A4 (en) Cell cultivation method, cell support composite production method, cultivated cells, and cell support composite
EP3587559A4 (en) Production method for artificial pluripotent stem cells
IL281231A (en) Methods of continuous cell culture
PH12019501133A1 (en) Manufacturing optimization of gl-2045, a multimerizing stradomer
MX369097B (en) Method for expanding adult stem cells from whole blood.